Acta Med. 2019, 62: 131-136
https://doi.org/10.14712/18059694.2020.1
Pancreatic Adenocarcinoma: Epidemiology, Role of EUS in Diagnosis, Role of ERCP, Endoscopic Palliation
References
1. Cancer Research UK. Accessed in May 2019. https://www.cancer researchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer.
2. World Health Organisation. Cancer Today. International Agency for Research on Cancer. Accessed May 2019. http://gco.iarc.fr/today/home.
3. S, Chawla S, Garg PK. Modifiable and non-modifiable risk factors for pancreatic cancer: A review. Cancer Lett 2016; 381(1): 269–77.
<https://doi.org/10.1016/j.canlet.2016.07.022>
4. L, Liu Q, Zhang R, et al. Tumor size classification of the 8th edition of TNM staging system is superior to that of the 7th edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy. Sci Rep 2018; 8(1): 10383.
<https://doi.org/10.1038/s41598-018-28193-4>
<PubMed>
5. A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic Cancer. Lancet 2011; 378(9791): 607–20.
<https://doi.org/10.1016/S0140-6736(10)62307-0>
<PubMed>
6. S, Kaneko T, Takeda S, Inoue S, Nakao A. Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB (Oxford) 2005; 7(2): 129–34.
<https://doi.org/10.1080/13651820510003744>
<PubMed>
7. SV, Barreto SG, Goel M, Arya S. Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. HPB 2012; 14(10): 658–68.
<https://doi.org/10.1111/j.1477-2574.2012.00508.x>
<PubMed>
8. JG, Wiersema MJ, Farrell MA, et al. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 2003; 229(1): 81–90.
<https://doi.org/10.1148/radiol.2291020582>
9. SP, Horton KM, Fishman EK. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography. Cancer J 2012; 18(6): 511–22.
<https://doi.org/10.1097/PPO.0b013e318274a461>
10. D, Pinson CW. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg 2004; 11(1): 4–10.
<https://doi.org/10.1007/s00534-002-0775-x>
11. P, Pauls S, Gress TM. Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 20(2): 227–51.
<https://doi.org/10.1016/j.bpg.2005.10.005>
12. F, Savides T, Cummings O, et al. Radial scanning and linear array endosonography for staging pancreatic cancer: a prospective randomized comparison. Gastrointest Endosc 1997; 45(2): 138–42.
<https://doi.org/10.1016/S0016-5107(97)70236-0>
13. J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004; 141(10): 753–63.
<https://doi.org/10.7326/0003-4819-141-10-200411160-00006>
14. MV, Varadarajulu S, Napoleon B. EUS contrast agents: what is available, how do they work, and are they effective? Gastrointest Endosc 2009; 69(2 Suppl): S71–7.
<https://doi.org/10.1016/j.gie.2008.12.004>
15. P, Spada A, Mancino MG, Caletti G. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol 2010; 8(7): 629–34. e1–2.
<https://doi.org/10.1016/j.cgh.2010.04.012>
16. WM, Adler DG, Chand B, et al. Echoendoscopes. Gastrointest Endosc 2007; 66(3): 435–42.
<https://doi.org/10.1016/j.gie.2007.05.028>
17. Garcia J, Dominguez-Munoz JE. Endoscopic ultrasound-guided biopsy for the evaluation of pancreatic tumors. Gastroenterol Hepatol 2007; 30(10): 597–601.
<https://doi.org/10.1157/13112588>
18. D, Penman I, Mishra G, Draganov P. EUS-guided celiac block and neurolysis. Endoscopy 2006; 38(9): 935–9.
<https://doi.org/10.1055/s-2006-944734>
19. T, Cote GA, Creach KM, Kohlmeier C, Parikh PJ, Azar RR. Fiducial placement for stereotactic radiation by using EUS: feasibility when using a marker compatible with a standard 22-gauge needle. Gastrointest Endosc 2010; 71(3): 630–3.
<https://doi.org/10.1016/j.gie.2009.11.023>
20. WG, Yan BM, Schellenberg D, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc 2010; 71(3): 513–8.
<https://doi.org/10.1016/j.gie.2009.10.030>
21. MK, Moser AJ, Khalid A, et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc 2010; 71(7): 1178–84.
<https://doi.org/10.1016/j.gie.2009.12.020>
22. T, Itokawa F, Tsuchiya T, Tsuji S, Tonozuka R. Endoscopic ultrasound- guided choledochoantrostomy as an alternative extrahepatic bile duct drainage method in pancreatic cancer with duodenal invasion. Dig Endosc 2013; 25(Suppl 2): 142–5.
<https://doi.org/10.1111/den.12065>
23. SJ, Choi JH, Park DH, et al. Expanding indication: EUS-guided hepaticoduodenostomy for isolated right intrahepatic duct obstruction (with video). Gastrointest Endosc 2013; 78: 374–80.
<https://doi.org/10.1016/j.gie.2013.04.183>
24. M, Artifon EL, Perez-Miranda M, et al. Endoscopic ultrasonography guided biliary drainage: summary of consortium meeting May 7th, 2011, Chicago. World J Gastroenterol 2013; 19(9): 1372–9.
<https://doi.org/10.3748/wjg.v19.i9.1372>
<PubMed>
25. R, Pérez-Miranda M, Will U, et al. EUS-guided choledochoduodenostomy for malignant distal biliary obstruction using a lumen- apposing fully covered metal stent after failed ERCP. Surg Endosc 2016; 30: 5002–8.
<https://doi.org/10.1007/s00464-016-4845-6>
26. EL, Aparicio D, Paione JB, et al. Biliary drainage in patients with unresectable, malignant obstruction where ERCP fails: endoscopic ultrasonography-guided choledochoduodenostomy versus percutaneous drainage. J Clin Gastroenterol 2012; 46(9): 768–74.
<https://doi.org/10.1097/MCG.0b013e31825f264c>
27. MB, Sabbagh LC. EUS 2008 Working Group document: evaluation of EUS-guided tumor ablation. Gastrointest Endosc 2009; 69(2 Suppl): S59–63.
<https://doi.org/10.1016/j.gie.2008.11.010>
28. S, Peters TJ, Neal RD, Rose PW, Walter FM, Hamilton W. The risk of pancreatic cancer in symptomatic patients in primary care: a large case-control study using electronic records. Br J Cancer 2012; 106(12): 1940–4.
<https://doi.org/10.1038/bjc.2012.190>
<PubMed>
29. AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 2007; 33(2): 213–21.
<https://doi.org/10.1016/j.ctrv.2006.10.006>
30. S, Olsen M, Jendresen MB, Holck S, Glenthoj A. Endobiliary brush biopsy: intra- and interobserver variation in cytological evaluation of brushings from bile duct strictures. Scand J Gastroenterol 2006; 41(5): 597–603.
<https://doi.org/10.1080/00365520500389099>
31. H, Siddiqui AA. Endosonographic workup and preoperative biliary drainage for pancreatic cancer. Semin Oncol 2015; 42(1): 59–69.
<https://doi.org/10.1053/j.seminoncol.2014.12.006>
32. J, Fogel EL, Sherman S, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 2000; 51(4 Pt 1): 383–90.
<https://doi.org/10.1016/S0016-5107(00)70435-4>
33. JJ, Heger M, van der Gaag NA, et al. Effect of preoperative biliary drainage on coagulation and fibrinolysis in severe obstructive cholestasis. J Clin Gastroenterol 2010; 44(9): 646–52.
<https://doi.org/10.1097/MCG.0b013e3181ce5b36>
34. EA, Baron TH. Preoperative biliary stents in pancreatic cancer. J Hepatobiliary Pancreat Sci 2011; 18(5): 621–9.
<https://doi.org/10.1007/s00534-011-0403-8>
35. P, Kumbhari V, Zein ME, Khashab MA. Preoperative biliary drainage. Dig Endosc 2015; 27(2): 265–77.
<https://doi.org/10.1111/den.12394>
36. C, Christein JD, Phadnis MA, Wilcox CM, Varadarajulu S. Biliary metal stents are superior to plastic stents for preoperative biliary decompression in pancreatic cancer. Surg Endosc 2011; 25(7): 2364–7.
<https://doi.org/10.1007/s00464-010-1552-6>
<PubMed>
37. BR. Biliary stents for pancreas cancer with obstruction: the problem with plastic. J Gastrointest Oncol 2012; 3(4): 306–8.


